InvestorsHub Logo
Followers 0
Posts 51
Boards Moderated 0
Alias Born 07/15/2012

Re: Dodgeball post# 6124

Tuesday, 02/16/2021 7:43:02 PM

Tuesday, February 16, 2021 7:43:02 PM

Post# of 6939
SESN has more than enough to get to approval and commercialization--the ATM in January was $55 million--and there will be more money coming from partnerships (likely Europe this time)--no AdCOM, PDUFA now August 18--this will get approval--the only question is whether either Merck or Astra Zeneca will buyout SESN or in the least form a strategic partnership--Merck markets Keytruda and Vicinium will be preferred for NMIBC over Keytruda due to its far less side effect profile so I suspect it will be Merck making an offer (or even better a "bidding war" after approval)